PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97575775 |
Filing Date: 09/01/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97575775 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\975\757\97575775\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | KITE |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a stylized design of a kite adjacent to the word "Kite". |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 645 x 260 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Kite Pharma, Inc. |
*MAILING ADDRESS | 2400 Broadway |
*CITY | Santa Monica |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
90404 |
PHONE | 650-574-3000 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | pharmaceutical preparations for use in the treatment of cancer and hematological diseases and disorders; biological preparations for use in the treatment of cancer and hematological diseases and disorders; pharmaceutical and biological preparations for immunotherapy, including cell therapy |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 08/22/2022 |
FIRST USE IN COMMERCE DATE | At least as early as 08/22/2022 |
SPECIMEN FILE NAME(S) | \\TICRS\EXPORT18\IMAGEOUT 18\975\757\97575775\xml1 \ APP0003.JPG |
SPECIMEN DESCRIPTION | photograph of Applicant's product label |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ATTORNEY INFORMATION | |
NAME | Cynthia Smuzynska |
ATTORNEY DOCKET NUMBER | 09501-US-NF2 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Gilead Sciences, Inc. |
STREET | 333 Lakeside Drive |
CITY | Foster City |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 94404 |
PHONE | 650-522-5563 |
EMAIL ADDRESS | trademarks@gilead.com |
OTHER APPOINTED ATTORNEY | Gretchen R. Stroud; Jack Wessel; Lori Mayall; Shelley Lai; Peter Colosi |
CORRESPONDENCE INFORMATION | |
NAME | Cynthia Smuzynska |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@gilead.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | tmteams@gilead.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /cynthia smuzynska/ |
SIGNATORY'S NAME | Cynthia Smuzynska |
SIGNATORY'S POSITION | Sr Counsel II, IP |
SIGNATORY'S PHONE NUMBER | 650-522-5563 |
DATE SIGNED | 09/01/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97575775 |
Filing Date: 09/01/2022 |
The applicant's current Correspondence Information: |
Cynthia Smuzynska |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmteams@gilead.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|